Zhao Lin
Impact in
- Cancer Research top 0.5%
- Cancer, Hypoxia, and Metabolism
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
- Molecular Biology top 5%
- Metabolism, Diabetes, and Cancer
- Epigenetics and DNA Methylation
- Mitochondrial Function and Pathology
Papers in
-
- Cancer, Hypoxia, and Metabolism 22
- Cancer-related molecular mechanisms research 11
- MicroRNA in disease regulation 6
-
- Metabolism, Diabetes, and Cancer 8
- Circular RNAs in diseases 5
- Mitochondrial Function and Pathology 5
- RNA modifications and cancer 4
- Co-authors
- Ubaldo Martinez‐Outschoorn (18 shared papers)Michael P. Lisanti (12 shared papers)Federica Sotgia (12 shared papers)Anthony Howell (10 shared papers)Richard G. Pestell (8 shared papers)Stephanos Pavlides (7 shared papers)Neal Flomenberg (6 shared papers)Diana Whitaker‐Menezes (12 shared papers)
- Journals
- Cell Cycle (8 papers)Journal of Biological Chemistry (3 papers)Cancer Biology & Therapy (2 papers)Oncotarget (2 papers)Seminars in Oncology (2 papers)
- Partner nations
- ChinaUnited StatesUnited Kingdom
In The Last Decade
Zhao Lin
41 papers receiving 2.9k citations
Peers
Comparison fields: 5 of 115
- Cancer Research 1.8k
- Molecular Biology 2.1k
- Oncology 636
- Biochemistry 95
- Immunology 260
Countries citing papers authored by Zhao Lin
This map shows the geographic impact of Zhao Lin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zhao Lin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zhao Lin more than expected).
Fields of papers citing papers by Zhao Lin
This network shows the impact of papers produced by Zhao Lin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zhao Lin. The network helps show where Zhao Lin may publish in the future.
Co-authors
The 25 scholars most cited alongside Zhao Lin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 43 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2010 | 393 | |
| 2 | 2011 | 339 | |
| 3 | 2011 | 283 | |
| 4 | 2011 | 233 | |
| 5 | 2012 | 200 | |
| 6 | 2010 | 172 | |
| 7 | 2011 | 140 | |
| 8 | 2012 | 110 | |
| 9 | 2011 | 99 | |
| 10 | 2006 | 97 | |
| 11 | 2013 | 69 | |
| 12 | 2007 | 64 | |
| 13 | 2012 | 63 | |
| 14 | 2021 | 61 | |
| 15 | 2021 | 59 | |
| 16 | 2016 | 59 | |
| 17 | 2017 | 57 | |
| 18 | 2017 | 52 | |
| 19 | 2017 | 49 | |
| 20 | 2019 | 35 |
About Zhao Lin
Zhao Lin is a scholar working on Cancer Research, Molecular Biology, Oncology, Physiology and Epidemiology, having authored 43 papers that have together received 3.0k indexed citations. Recurring topics across this work include Cancer, Hypoxia, and Metabolism (22 papers), Cancer-related molecular mechanisms research (11 papers), Metabolism, Diabetes, and Cancer (8 papers), MicroRNA in disease regulation (6 papers), Circular RNAs in diseases (5 papers), Mitochondrial Function and Pathology (5 papers), Adipose Tissue and Metabolism (4 papers) and RNA modifications and cancer (4 papers). The work is most often cited by research in Cancer Research (1.8k citations), Molecular Biology (2.1k citations), Oncology (636 citations), Biochemistry (95 citations) and Immunology (260 citations). Zhao Lin has collaborated with scholars based in China, United States and United Kingdom. Frequent co-authors include Ubaldo Martinez‐Outschoorn, Michael P. Lisanti, Federica Sotgia, Anthony Howell, Richard G. Pestell, Stephanos Pavlides, Neal Flomenberg, Diana Whitaker‐Menezes, Agnieszka K. Witkiewicz and Chenguang Wang. Their work appears in journals such as Cell Cycle, Journal of Biological Chemistry, Cancer Biology & Therapy, Oncotarget and Seminars in Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.